Delivery Order SPE2DB24D3015-SPE2DB25FFYDH
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, delivered under a delivery order with a fixed-price contract. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $37,104.27. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
The federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $41,031.57 firm fixed-price delivery order contract has a completion date of December 9, 2024. This award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $1,578.00 and is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award is for the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML, with a ceiling value of $6,395.58. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 14, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
The federal contract award is for the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $3,991.12 and an ultimate completion date of October 28, 2024. The contract was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. AmerisourceBergen Drug Corp...
The federal contract award is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,263.75. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. This is a delivery order contract with a firm fixed price pricing type, and an ultimate completion date of November 27, 2024. The contract does not have a set-aside designation,...
The federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,544.72 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, on November 6, 2024, with a completion date of November 7, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, which was awarded to the prime contractor Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract, valued at $1,169.99, is a firm fixed-price delivery order with a completion date of October 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award from the Defense Logistics Agency (DLA) is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract, valued at $7,898.76, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $11,147.42 firm fixed price contract was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 3, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...